cannabis drug ipo candidates
Secure Funding for Cannabis Drug IPOs Before Reclassification
Secure Funding for Cannabis Drug IPOs Before Reclassification Five cannabis drug companies have secured $1.2 billion in private capital ahead of the 2026 reclassification, positioning them for public offerings within the next two years. The influx of funding reflects investor confidence that clearer federal rules will shorten FDA pathways